Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Androgen | 6 | 2022 | 1058 | 1.260 |
Why?
|
Computational Biology | 2 | 2023 | 3521 | 0.360 |
Why?
|
Prostatic Neoplasms | 5 | 2022 | 11124 | 0.320 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2023 | 8428 | 0.280 |
Why?
|
Chromosomal Proteins, Non-Histone | 3 | 2021 | 736 | 0.280 |
Why?
|
Workflow | 2 | 2021 | 847 | 0.250 |
Why?
|
Transcription Factors | 8 | 2023 | 12208 | 0.230 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 2 | 2021 | 170 | 0.230 |
Why?
|
Cell Line, Tumor | 12 | 2023 | 16689 | 0.230 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2022 | 1101 | 0.230 |
Why?
|
Chromatin | 5 | 2023 | 2934 | 0.230 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2021 | 185 | 0.190 |
Why?
|
Inflammatory Breast Neoplasms | 1 | 2023 | 143 | 0.190 |
Why?
|
Genes, myc | 1 | 2022 | 399 | 0.190 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2022 | 5172 | 0.180 |
Why?
|
Cyclic AMP Response Element-Binding Protein A | 1 | 2019 | 21 | 0.180 |
Why?
|
SOXB1 Transcription Factors | 1 | 2021 | 284 | 0.170 |
Why?
|
Adenosine Deaminase | 1 | 2021 | 241 | 0.170 |
Why?
|
Androgen Receptor Antagonists | 1 | 2019 | 114 | 0.170 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2023 | 388 | 0.160 |
Why?
|
Breast Neoplasms | 6 | 2023 | 20822 | 0.160 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 528 | 0.160 |
Why?
|
Carcinoma, Lobular | 1 | 2022 | 484 | 0.160 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 44 | 0.160 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2021 | 332 | 0.150 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3597 | 0.150 |
Why?
|
Sequence Analysis, RNA | 3 | 2023 | 2012 | 0.150 |
Why?
|
Software | 3 | 2023 | 4443 | 0.150 |
Why?
|
Epigenomics | 4 | 2023 | 903 | 0.140 |
Why?
|
Prostate | 2 | 2022 | 1774 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2022 | 987 | 0.140 |
Why?
|
Lymphoma, T-Cell | 1 | 2018 | 299 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 380 | 0.130 |
Why?
|
Enhancer Elements, Genetic | 2 | 2021 | 1341 | 0.130 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2022 | 2942 | 0.130 |
Why?
|
Neuroendocrine Tumors | 1 | 2021 | 594 | 0.130 |
Why?
|
NF-kappa B | 1 | 2023 | 2499 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2019 | 794 | 0.120 |
Why?
|
Melanoma, Experimental | 1 | 2018 | 561 | 0.120 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2018 | 1369 | 0.120 |
Why?
|
Estrogen Receptor alpha | 1 | 2018 | 577 | 0.120 |
Why?
|
Androgen Antagonists | 1 | 2022 | 1377 | 0.110 |
Why?
|
RNA | 1 | 2023 | 2749 | 0.110 |
Why?
|
Nuclear Proteins | 4 | 2023 | 5853 | 0.110 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 1941 | 0.110 |
Why?
|
BRCA1 Protein | 1 | 2019 | 1149 | 0.110 |
Why?
|
RNA-Binding Proteins | 1 | 2021 | 1903 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2021 | 2948 | 0.100 |
Why?
|
Testosterone | 1 | 2022 | 2420 | 0.100 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13695 | 0.100 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 1583 | 0.100 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2018 | 1821 | 0.090 |
Why?
|
Models, Genetic | 1 | 2020 | 3494 | 0.090 |
Why?
|
Sequence Analysis, DNA | 1 | 2021 | 4803 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2183 | 0.090 |
Why?
|
Cell Lineage | 1 | 2018 | 2504 | 0.090 |
Why?
|
RNA, Double-Stranded | 2 | 2021 | 290 | 0.090 |
Why?
|
Pyrimidines | 1 | 2021 | 2942 | 0.090 |
Why?
|
Mutation | 4 | 2023 | 29786 | 0.080 |
Why?
|
Phenylthiohydantoin | 2 | 2019 | 193 | 0.080 |
Why?
|
Interferons | 2 | 2021 | 706 | 0.070 |
Why?
|
Humans | 26 | 2023 | 744343 | 0.070 |
Why?
|
Alleles | 1 | 2018 | 6933 | 0.070 |
Why?
|
Peptides | 1 | 2018 | 4409 | 0.070 |
Why?
|
Paclitaxel | 2 | 2023 | 1708 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 1 | 2018 | 4554 | 0.070 |
Why?
|
Proteins | 1 | 2020 | 6103 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7722 | 0.060 |
Why?
|
Neoplasms | 2 | 2023 | 21683 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2018 | 9648 | 0.060 |
Why?
|
Nitriles | 2 | 2019 | 956 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9239 | 0.060 |
Why?
|
Benzamides | 2 | 2019 | 1379 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6364 | 0.060 |
Why?
|
Protein Binding | 3 | 2021 | 9386 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 12072 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2021 | 3557 | 0.050 |
Why?
|
Mice | 7 | 2023 | 81183 | 0.050 |
Why?
|
Male | 8 | 2022 | 350118 | 0.050 |
Why?
|
Histone Demethylases | 1 | 2023 | 321 | 0.050 |
Why?
|
Signal Transduction | 5 | 2023 | 23403 | 0.050 |
Why?
|
Endogenous Retroviruses | 1 | 2021 | 112 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2020 | 4204 | 0.050 |
Why?
|
Animals | 9 | 2023 | 168757 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3586 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2019 | 49 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 513 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13102 | 0.040 |
Why?
|
Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
STAT3 Transcription Factor | 1 | 2023 | 873 | 0.040 |
Why?
|
Introns | 1 | 2021 | 991 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3647 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5686 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2021 | 504 | 0.040 |
Why?
|
Cell Survival | 2 | 2018 | 5882 | 0.040 |
Why?
|
Base Sequence | 2 | 2021 | 12797 | 0.040 |
Why?
|
HMGB Proteins | 1 | 2018 | 45 | 0.040 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 113 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1157 | 0.040 |
Why?
|
Azepines | 1 | 2020 | 336 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 705 | 0.040 |
Why?
|
Tamoxifen | 1 | 2022 | 981 | 0.040 |
Why?
|
Depsipeptides | 1 | 2018 | 94 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2023 | 1284 | 0.040 |
Why?
|
Cell Cycle Proteins | 2 | 2020 | 3462 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1792 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 996 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2021 | 635 | 0.040 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 217 | 0.040 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2020 | 794 | 0.040 |
Why?
|
Open Reading Frames | 1 | 2019 | 810 | 0.030 |
Why?
|
DNA Helicases | 1 | 2021 | 859 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1114 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1878 | 0.030 |
Why?
|
Amino Acids | 1 | 2021 | 1736 | 0.030 |
Why?
|
Immunotherapy | 2 | 2023 | 4445 | 0.030 |
Why?
|
Acetylation | 1 | 2018 | 1085 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2021 | 1119 | 0.030 |
Why?
|
Organoids | 1 | 2021 | 701 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2505 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 528 | 0.030 |
Why?
|
Endonucleases | 1 | 2018 | 380 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2023 | 9438 | 0.030 |
Why?
|
Triazoles | 1 | 2020 | 911 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2022 | 2187 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2023 | 2421 | 0.030 |
Why?
|
Disease Progression | 2 | 2021 | 13284 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2023 | 2416 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2018 | 2256 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2023 | 2915 | 0.030 |
Why?
|
Female | 8 | 2023 | 380194 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1375 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2513 | 0.030 |
Why?
|
Remission Induction | 1 | 2018 | 2386 | 0.030 |
Why?
|
RNA Interference | 1 | 2021 | 2889 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1788 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2018 | 2715 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 3002 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2727 | 0.020 |
Why?
|
Stem Cells | 1 | 2023 | 3567 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 1524 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3505 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2018 | 3206 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 1596 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2849 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4217 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 5867 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4420 | 0.020 |
Why?
|
Histones | 1 | 2018 | 2599 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5720 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4851 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4479 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2018 | 3023 | 0.020 |
Why?
|
Apoptosis | 1 | 2023 | 9727 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15997 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11366 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9734 | 0.020 |
Why?
|
Genetic Testing | 1 | 2018 | 3444 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2018 | 3848 | 0.010 |
Why?
|
DNA Methylation | 1 | 2018 | 4286 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10481 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2018 | 13033 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 21746 | 0.010 |
Why?
|
Prognosis | 1 | 2022 | 29063 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11524 | 0.010 |
Why?
|
Aged | 1 | 2018 | 163280 | 0.000 |
Why?
|
Middle Aged | 1 | 2018 | 213383 | 0.000 |
Why?
|
Adult | 1 | 2018 | 214055 | 0.000 |
Why?
|